Sherif Farag

  • 4139 Citations
  • 32 h-Index
1977 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Publications

Article

Addition of Infliximab to Standard Acute Graft-versus-Host Disease Prophylaxis following Allogeneic Peripheral Blood Cell Transplantation

Hamadani, M., Hofmeister, C. C., Jansak, B., Phillips, G., Elder, P., Blum, W., Penza, S., Lin, T. S., Klisovic, R., Marcucci, G., Farag, S. S. & Devine, S. M., Jul 1 2008, In : Biology of Blood and Marrow Transplantation. 14, 7, p. 783-789 7 p.

Research output: Contribution to journalArticle

41 Scopus citations

A novel high throughput immunomagnetic cell sorting system for potential clinical scale depletion of T cells for allogeneic stem cell transplantation

Tong, X., Xiong, Y., Zborowski, M., Farag, S. S. & Chalmers, J. J., Oct 2007, In : Experimental Hematology. 35, 10, p. 1613-1622 10 p.

Research output: Contribution to journalArticle

22 Scopus citations

Antimyeloma effects of a sesquiterpene lactone parthenolide

Suvannasankha, A., Crean, C. D., Shanmugam, R., Farag, S. S., Abonour, R., Boswell, H. S. & Nakshatri, H., Mar 15 2008, In : Clinical Cancer Research. 14, 6, p. 1814-1822 9 p.

Research output: Contribution to journalArticle

32 Scopus citations

Aphase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma

Benson, D. M., Hofmeister, C. C., Padmanabhan, S., Suvannasankha, A., Jagannath, S., Abonour, R., Bakan, C., Andre, P., Efebera, Y., Tiollier, J., Caligiuri, M. A. & Farag, S. S., Nov 22 2012, In : Blood. 120, 22, p. 4324-4333 10 p.

Research output: Contribution to journalArticle

147 Scopus citations

A phase I trial of flavopiridol in relapsed multiple myeloma

Hofmeister, C. C., Poi, M., Bowers, M. A., Zhao, W., Phelps, M. A., Benson, D. M., Kraut, E. H., Farag, S., Efebera, Y. A., Sexton, J., Lin, T. S., Grever, M. & Byrd, J. C., Feb 2014, In : Cancer Chemotherapy and Pharmacology. 73, 2, p. 249-257 9 p.

Research output: Contribution to journalArticle

25 Scopus citations

A phase I trial of high-dose clofarabine, etoposide, and cyclophosphamide and autologous peripheral blood stem cell transplantation in patients with primary refractory and relapsed and refractory Non-Hodgkin lymphoma

Srivastava, S., Jones, D., Wood, L. L., Schwartz, J. E., Nelson, R. P., Abonour, R., Secrest, A., Cox, E., Baute, J., Sullivan, C., Kane, K., Robertson, M. J. & Farag, S. S., Jul 1 2011, In : Biology of Blood and Marrow Transplantation. 17, 7, p. 987-994 8 p.

Research output: Contribution to journalArticle

6 Scopus citations

Aurora kinase A inhibitor protein kinase inhibitor oncolytic

Zhang, S. & Farag, S., 2011, In : Drugs of the Future. 36, 1, p. 5-15 11 p.

Research output: Contribution to journalArticle

1 Scopus citations

Autologous and allogeneic hematopoietic stem cell transplantation (HCT) in multiple myeloma (MM): a single institution experience

Farag, S. S., Hike, S., Elder, P. J., Marcucci, G., Penza, S. L., Mrozek, E., Avalos, B. R. & Copelan, E. A., Dec 1 2000, In : Blood. 96, 11 PART II, p. 354b

Research output: Contribution to journalArticle

16 Scopus citations

Blood progenitor cell separation from clinical leukapheresis product by magnetic nanoparticle binding and magnetophoresis

Jing, Y., Moore, L. R., Williams, P. S., Chalmers, J. J., Farag, S. S., Bolwell, B. & Zborowski, M., Apr 15 2007, In : Biotechnology and Bioengineering. 96, 6, p. 1139-1154 16 p.

Research output: Contribution to journalArticle

88 Scopus citations
2 Scopus citations

Comparison of reduced-intensity hematopoietic cell transplantation with chemotherapy in patients age 60-70 years with acute myelogenous leukemia in first remission

Farag, S. S., Maharry, K., Zhang, M. J., Pérez, W. S., George, S. L., Mrózek, K., DiPersio, J., Bunjes, D. W., Marcucci, G., Baer, M. R., Cairo, M., Copelan, E., Cutler, C. S., Isola, L., Lazarus, H. M., Litzow, M. R., Marks, D. I., Ringdén, O., Rizzieri, D. A., Soiffer, R. & 4 others, Larson, R. A., Tallman, M. S., Bloomfield, C. D. & Weisdorf, D. J., Dec 1 2011, In : Biology of Blood and Marrow Transplantation. 17, 12, p. 1796-1803 8 p.

Research output: Contribution to journalArticle

81 Scopus citations

Comparison of two immunomagnetic separation technologies to deplete T cells from human blood samples

Lara, O., Tong, X., Zborowski, M., Farag, S. S. & Chalmers, J. J., May 5 2006, In : Biotechnology and Bioengineering. 94, 1, p. 66-80 15 p.

Research output: Contribution to journalArticle

27 Scopus citations

Cyclophosphamide/fludarabine nonmyeloablative allotransplant for acute myeloid leukemia

Khawaja, M. R., Perkins, S. M., Schwartz, J. E., Robertson, M. J., Kiel, P. J., Sayar, H., Cox, E. A., Vance, G. H., Farag, S. S., Cripe, L. D. & Nelson, R. P., Feb 1 2015, In : American Journal of Hematology. 90, 2, p. 97-99 3 p.

Research output: Contribution to journalArticle

Delay by internists in obtaining diagnostic biopsies in patients with suspected cancer

Farag, S. S., Green, M. D., Morstyn, G., Sheridan, W. P. & Fox, R. M., Jan 1 1992, In : Annals of internal medicine. 116, 6, p. 473-478 6 p.

Research output: Contribution to journalArticle

16 Scopus citations

Differential action of diffusible molecules in long‐term marrow culture on proliferation of leukaemic and normal haemopoietic cells

Firkin, F. C., Birner, R. & Farag, S., May 1993, In : British journal of haematology. 84, 1, p. 8-15 8 p.

Research output: Contribution to journalArticle

12 Scopus citations

Differential stem-and progenitor-cell trafficking by prostaglandin e 2

Hoggatt, J., Mohammad, K. S., Singh, P., Hoggatt, A. F., Chitteti, B. R., Speth, J. M., Hu, P., Poteat, B. A., Stilger, K. N., Ferraro, F., Silberstein, L., Wong, F. K., Farag, S. S., Czader, M., Milne, G. L., Breyer, R. M., Serezani, C. H., Scadden, D. T., Guise, T. A., Srour, E. F. & 1 others, Pelus, L. M., Mar 21 2013, In : Nature. 495, 7441, p. 365-369 5 p.

Research output: Contribution to journalArticle

84 Scopus citations

Dipeptidylpeptidase 4 negatively regulates colony-stimulating factor activity and stress hematopoiesis

Broxmeyer, H. E., Hoggatt, J., O'leary, H. A., Mantel, C., Chitteti, B. R., Cooper, S., Messina-Graham, S., Hangoc, G., Farag, S., Rohrabaugh, S. L., Ou, X., Speth, J., Pelus, L. M., Srour, E. F. & Campbell, T. B., Dec 1 2012, In : Nature Medicine. 18, 12, p. 1786-1796 11 p.

Research output: Contribution to journalArticle

129 Scopus citations

Effect of Sirolimus levels between days 11 and 20 after allogeneic stem cell transplantation on the risk of hepatic sinusoidal obstruction syndrome

Agrawal, V., Ranganath, P., Ervin, K. D., Schmidt, C. A., Cox, E. A., Nelson, R. P., Schwartz, J. E., Zaid, M. A., Abonour, R., Robertson, M. J., Brinda, B. J., Griffin, S. P., Thakrar, T. C. & Farag, S. S., 2020, (Accepted/In press) In : Bone marrow transplantation.

Research output: Contribution to journalArticle

Fatal disseminated Scedosporium inflatum infection in a neutropenic immunocompromised patient

Farag, S. S., Firkin, F. C., Andrew, J. H., Soon Lee, C. & Ellis, D. H., Sep 1992, In : Journal of Infection. 25, 2, p. 201-202,IN7-IN8,203-204

Research output: Contribution to journalArticle

24 Scopus citations

FCGR3A and FCGR2A polymorphisms may not correlate with response to alemtuzumab in chronic lymphocytic leukemia

Lin, T. S., Flinn, I. W., Modali, R., Lehman, T. A., Webb, J., Waymer, S., Moran, M. E., Lucas, M. S., Farag, S. S. & Byrd, J. C., Jan 1 2005, In : Blood. 105, 1, p. 289-291 3 p.

Research output: Contribution to journalArticle

66 Scopus citations

FcγRIIIa and FcγRIIa polymorphisms do not predict response to rituximab in B-cell chronic lymphocytic leukemia

Farag, S. S., Flinn, I. W., Modali, R., Lehman, T. A., Young, D. & Byrd, J. C., Feb 15 2004, In : Blood. 103, 4, p. 1472-1474 3 p.

Research output: Contribution to journalArticle

177 Scopus citations

From cell biology to therapy: ENMD-2076 in the treatment of multiple myeloma

Zhang, S. & Farag, S. S., Jul 1 2011, In : Expert Opinion on Investigational Drugs. 20, 7, p. 1015-1028 14 p.

Research output: Contribution to journalArticle

4 Scopus citations

High disease burden is associated with poor outcomes for patients with acute myeloid leukemia not in remission who undergo unrelated donor cell transplantation

Blum, W., Bolwell, B. J., Phillips, G., Farag, S. S., Lin, T. S., Avalos, B. R., Penza, S. L., Marcucci, G., Byrd, J. C., Kalaycio, M. E., Sobecks, R. M., Pohlman, B., Brown, S., Elder, P. J. & Copelan, E. A., Jan 1 2006, In : Biology of Blood and Marrow Transplantation. 12, 1, p. 61-67 7 p.

Research output: Contribution to journalArticle

15 Scopus citations

High-dose busulfan, cyclophosphamide, and etoposide does not improve outcome of allogeneic stem cell transplantation compared to BuCy2 in patients with acute myeloid leukemia

Farag, S. S., Bolwell, B. J., Elder, P. J., Kalaycio, M., Lin, T., Pohlman, B., Penza, S., Marcucci, G., Blum, W., Sobecks, R., Avalos, B. R., Byrd, J. C. & Copelan, E., Apr 1 2005, In : Bone Marrow Transplantation. 35, 7, p. 653-661 9 p.

Research output: Contribution to journalArticle

16 Scopus citations

High-dose melphalan versus busulfan, cyclophosphamide, and etoposide as preparative regimens for autologous stem cell transplantation in patients with multiple myeloma

Benson, D. M., Elder, P. J., Lin, T. S., Blum, W., Penza, S., Avalos, B., Copelan, E. & Farag, S. S., Aug 2007, In : Leukemia Research. 31, 8, p. 1069-1075 7 p.

Research output: Contribution to journalArticle

22 Scopus citations

High-dose sitagliptin for systemic inhibition of dipeptidylpeptidase-4 to enhance engraftment of single cord umbilical cord blood transplantation

Farag, S. S., Nelson, R., Cairo, M. S., O'Leary, H. A., Zhang, S., Huntley, C., Delgado, D., Schwartz, J., Zaid, M. A., Abonour, R., Robertson, M. & Broxmeyer, H., 2017, In : Oncotarget. 8, 66, p. 110350-110357 8 p.

Research output: Contribution to journalArticle

12 Scopus citations

Human natural killer cell development and biology

Farag, S. S. & Caligiuri, M. A., May 1 2006, In : Blood Reviews. 20, 3, p. 123-137 15 p.

Research output: Contribution to journalArticle

321 Scopus citations

Immunologic Approaches to Acute Leukemia in the Elderly

Farag, S. S. & Caligiuri, M. A., Apr 1 2006, In : Seminars in Hematology. 43, 2, p. 118-125 8 p.

Research output: Contribution to journalArticle

10 Scopus citations

Immunotherapeutic strategies of stem cell transplant in lymphoma.

Farag, S. S., Oct 2004, In : Clinical advances in hematology & oncology : H&O. 2, 10, p. 638-640 3 p.

Research output: Contribution to journalArticle

In vivo DPP-4 inhibition to enhance engraftment of single-unit cord blood transplants in adults with hematological malignancies

Farag, S. S., Srivastava, S., Messina-Graham, S., Schwartz, J., Robertson, M. J., Abonour, R., Cornetta, K., Wood, L., Secrest, A., Strother, R. M., Jones, D. R. & Broxmeyer, H. E., Apr 1 2013, In : Stem Cells and Development. 22, 7, p. 1007-1015 9 p.

Research output: Contribution to journalArticle

74 Scopus citations

IPH2101, a novel anti-inhibitory KIR antibody, and lenalidomide combine to enhance the natural killer cell versus multiple myeloma effect

Benson, D. M., Bakan, C. E., Zhang, S., Collins, S. M., Liang, J., Srivastava, S., Hofmeister, C. C., Efebera, Y., Andre, P., Romagne, F., Bléry, M., Bonnafous, C., Zhang, J., Clever, D., Caligiuri, M. A. & Farag, S. S., Dec 8 2011, In : Blood. 118, 24, p. 6387-6391 5 p.

Research output: Contribution to journalArticle

122 Scopus citations

Isolated trisomy of chromosomes 8, 11, 13 and 21 is an adverse prognostic factor in adults with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B 8461.

Farag, S. S., Archer, K. J., Mrózek, K., Vardiman, J. W., Carroll, A. J., Pettenati, M. J., Moore, J. O., Kolitz, J. E., Mayer, R. J., Stone, R. M., Larson, R. A. & Bloomfield, C. D., Nov 2002, In : International journal of oncology. 21, 5, p. 1041-1051 11 p.

Research output: Contribution to journalArticle

38 Scopus citations

KIR B donors improve the outcome for AML patients given reduced intensity conditioning and unrelated donor transplantation

Weisdorf, D., Cooley, S., Wang, T., Trachtenberg, E., Vierra-Green, C., Spellman, S., A. Sees, J., Spahn, A., Vogel, J., Fehniger, T. A., Woolfrey, A. E., Devine, S. M., Ross, M., Waller, E. K., Sobecks, R. M., McGuirk, J., Oran, B., Farag, S. S., Shore, T., Van Besien, K. & 4 others, Marsh, S. G. E., Guethlein, L. A., Parham, P. & Miller, J. S., Feb 25 2020, In : Blood Advances. 4, 4, p. 740-754 15 p.

Research output: Contribution to journalArticle

Open Access
1 Scopus citations

Lack of in vitro cross-reactivity predicts safety of low-molecular weight heparins in heparin-induced thrombocytopenia

Farag, S. S., Savoia, H., O'Malley, C. J. & McGrath, K. M., Jan 1997, In : Clinical and Applied Thrombosis/Hemostasis. 3, 1, p. 58-62 5 p.

Research output: Contribution to journalArticle

4 Scopus citations

Leukocytoreduction for acute leukemia

Porcu, P., Farag, S., Marcucci, G., Cataland, S. R., Kennedy, M. S. & Bissell, M., Mar 23 2002, In : Therapeutic Apheresis. 6, 1, p. 15-23 9 p.

Research output: Contribution to journalArticle

109 Scopus citations
13 Scopus citations

Long-term Outcome of Hodgkin Disease Patients Following High-Dose Busulfan, Etoposide, Cyclophosphamide, and Autologous Stem Cell Transplantation

Wadehra, N., Farag, S., Bolwell, B., Elder, P., Penza, S., Kalaycio, M., Avalos, B., Pohlman, B., Marcucci, G., Sobecks, R., Lin, T., Andrèsen, S. & Copelan, E., Dec 1 2006, In : Biology of Blood and Marrow Transplantation. 12, 12, p. 1343-1349 7 p.

Research output: Contribution to journalArticle

33 Scopus citations
2 Scopus citations

Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT

Miller, J. S., Cooley, S., Parham, P., Farag, S. S., Verneris, M. R., McQueen, K. L., Guethlein, L. A., Trachtenberg, E. A., Haagenson, M., Horowitz, M. M., Klein, J. P. & Weisdorf, D. J., Jun 1 2007, In : Blood. 109, 11, p. 5058-5061 4 p.

Research output: Contribution to journalArticle

217 Scopus citations

Modelling the sitagliptin effect on dipeptidyl peptidase-4 activity in adults with haematological malignancies after umbilical cord blood haematopoietic cell transplantation

Vélez De Mendizábal, N., Strother, R. M., Farag, S. S., Broxmeyer, H. E., Messina-Graham, S., Chitnis, S. D. & Bies, R. R., Mar 1 2014, In : Clinical Pharmacokinetics. 53, 3, p. 247-259 13 p.

Research output: Contribution to journalArticle

16 Scopus citations

Monoclonal antibodies for the prevention and treatment of graft-versus-host disease

Bruner, R. J. & Farag, S. S., Aug 2003, In : Seminars in oncology. 30, 4, p. 509-519 11 p.

Research output: Contribution to journalArticle

25 Scopus citations

Multiple myeloma: Clinical practice guidelines in oncology™

Anderson, K. C., Alsina, M., Bensinger, W., Biermann, J. S., Chanan-Khan, A., Comenzo, R. L., De Castro, C. M., Djulbegovic, B., Farag, S., Huff, C. A., Meredith, R., Schriber, J., Shrieve, D., Singhal, S., Smith, M. R., Stockerl-Goldstein, K., Vose, J. M., Weber, D., Yahalom, J. & Yunus, F., Feb 1 2007, In : JNCCN Journal of the National Comprehensive Cancer Network. 5, 2, p. 118-147 30 p.

Research output: Contribution to journalArticle

32 Scopus citations

Natural killer cells: Biology and application in stem-cell transplantation

Farag, S. S., Fehniger, T., Ruggeri, L., Velardi, A. & Caligiuri, M. A., Jan 1 2002, In : Cytotherapy. 4, 5, p. 445-446 2 p.

Research output: Contribution to journalArticle

18 Scopus citations

Negative selection of hematopoietic progenitor cells by continuous magnetophoresis

Jing, Y., Moore, L. R., Schneider, T., Williams, P. S., Chalmers, J. J., Farag, S. S., Bolwell, B. & Zborowski, M., Apr 1 2007, In : Experimental Hematology. 35, 4, p. 662-672 11 p.

Research output: Contribution to journalArticle

21 Scopus citations

Novel translocation (2;4) with consistent involvement of 2p23 in acute nonlymphocytic leukemia (M2)

Farag, S., Challis, J., White, J. & Garson, O. M., Jan 1992, In : Cancer Genetics and Cytogenetics. 58, 1, p. 48-51 4 p.

Research output: Contribution to journalArticle

9 Scopus citations

OSU-03012, a novel celecoxib derivative, is cytotoxic to myeloma cells and acts through multiple mechanisms

Zhang, S., Suvannasankha, A., Crean, C. D., White, V. L., Johnson, A., Chen, C. S. & Farag, S. S., Aug 15 2007, In : Clinical Cancer Research. 13, 16, p. 4750-4758 9 p.

Research output: Contribution to journalArticle

45 Scopus citations

Outcome of induction and postremission therapy in younger adults with acute myeloid leukemia with normal karyotype: A cancer and leukemia group B study

Farag, S. S., Ruppert, A. S., Mrózek, K., Mayer, R. J., Stone, R. M., Carroll, A. J., Powell, B. L., Moore, J. O., Pettenati, M. J., Koduru, P. R. K., Stamberg, J., Baer, M. R., Block, A. W., Vardiman, J. W., Kolitz, J. E., Schiffer, C. A., Larson, R. A. & Bloomfield, C. D., 2005, In : Journal of Clinical Oncology. 23, 3, p. 482-493 12 p.

Research output: Contribution to journalArticle

111 Scopus citations

Phase 1 and pharmacodynamic studies of G3139, a Bcl-2 antisense oligonucleotide, in combination with chemotherapy in refractory or relapsed acute leukemia

Marcucci, G., Byrd, J. C., Dai, G., Klisovic, M. I., Kourlas, P. J., Young, D. C., Cataland, S. R., Fisher, D. B., Lucas, D., Chan, K. K., Porcu, P., Lin, Z. P., Farag, S. F., Frankel, S. R., Zwiebel, J. A., Kraut, E. H., Balcerzak, S. P., Bloomfield, C. D., Grever, M. R. & Caligiuri, M. A., Jan 15 2003, In : Blood. 101, 2, p. 425-432 8 p.

Research output: Contribution to journalArticle

188 Scopus citations

Phase II clinical trial of arsenic trioxide with liposomal doxorubicin, vincristine, and dexamethasone in newly diagnosed multiple myeloma

Hofmeister, C. C., Jansak, B., Denlinger, N., Kraut, E. H., Benson, D. M. & Farag, S. S., Aug 1 2008, In : Leukemia Research. 32, 8, p. 1295-1298 4 p.

Research output: Contribution to journalArticle

11 Scopus citations